Table 4.
Relative Efficacy of Each Intervention
Clinical Parameters | Surgical Intervention (%) | Optimal (%) | |||
---|---|---|---|---|---|
MoG | MfG | HmG | PmG | ||
UDVA | 96 | 97 | 95 | 97 | 100 |
UIRA | 92 | 95 | 94 | 95 | 100 |
UICPS | 76 | 87 | 82 | 89 | 100 |
UNRA | 77 | 95 | 92 | 93 | 100 |
UNCPS | 66 | 86 | 80 | 83 | 100 |
Glare | 92 | 53 | 74 | 72 | 100 |
Shadows | 82 | 49 | 71 | 69 | 100 |
CS | 87 | 80 | 83 | 81 | 100 |
SFP-NV | 27 | 90 | 77 | 87 | 100 |
SFP-DV | 87 | 83 | 83 | 93 | 100 |
SFP (total) | 27 | 77 | 70 | 83 | 100 |
Relative Efficacy | 70.78 | 88.49 | 87.89 | 92.18 | 100 |
Abbreviations: UDVA, uncorrected distance visual acuity; UIRA, uncorrected intermediate reading acuity (at 60 cm), UICPS, uncorrected intermediate critical print size (at 60 cm); UNRA, uncorrected near reading acuity (at 40 cm); UNCPS, uncorrected near critical print size (at 40 cm); CS, contrast sensitivity; HmG, Hybrid Monovision Group; MfG, Multifocal Lens Group; MoG, Monovision Group; PmG, Premium Monovision Group; SFP-NV, spectacle-free patient for near vision activities; SFP-DV, spectacle-free patient for distance vision activities; SFP (total), spectacle-free patient (all distances).